Multicenter Infection Surveillance Study Following Colorectal Procedures
- Conditions
- Surgical Wound Infection
- Interventions
- Device: ON-Q Silver soaker SystemDrug: Patient controlled analgesia
- Registration Number
- NCT00762060
- Lead Sponsor
- Halyard Health
- Brief Summary
This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal surgical procedures.
- Detailed Description
This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal procedures.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 289
- Men and women, >18 years of age;
- Scheduled for elective colon procedure;
- Ability to complete patient survey questionnaires;
- Provision of informed consent
- Patients with a prior allergic reaction to Morphine, Demerol, Dilaudid, Fentanyl, Marcaine (bupivacaine), lidocaine or Naropin (ropivacaine);
- Procedures for hemorrhoids;
- Inability to perform follow up assessments
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Active ON-Q Silver soaker System Surgical site continuous local anesthetic infusion with ONQ silver Soaker System Control Patient controlled analgesia Hospital standard of care for pain management (Patient controlled analgesia or epidural)
- Primary Outcome Measures
Name Time Method Surgical site infection 30 days postoperative
- Secondary Outcome Measures
Name Time Method Hospital length of stay Average 1 week